```html

Optic Neuritis: What You Need to Know

What is Optic Neuritis?

Optic neuritis (ON) is an inflammation of the optic nerve—the bundle of nerve fibers that carries visual information from the retina to the brain. The inflammation damages the myelin sheath (the protective coating) surrounding the nerve, leading to a sudden reduction in visual acuity, color vision, and sometimes painful eye movements. While most cases are acute and recover partially or completely within weeks, some individuals experience lasting visual deficits or recurrent episodes.

ON most commonly affects adults aged 20–45 years and is more prevalent in women. It can be the first manifestation of a systemic autoimmune disease (especially multiple sclerosis) or may occur in isolation.

Common Causes

Optic neuritis can be triggered by a wide range of conditions. The most frequent etiologies include:

• Multiple sclerosis (MS): Up to 50 % of patients with ON develop MS within 5–10 years.
• Neuromyelitis optica spectrum disorder (NMOSD): Often associated with anti‑AQP4 antibodies.
• Infectious agents:
  • Viral – measles, mumps, influenza, herpes simplex, varicella‑zoster.
  • Bacterial – syphilis, Lyme disease, tuberculosis.
  • Fungal – Candida, Aspergillus (rare).
• Autoimmune disorders: Systemic lupus erythematosus, sarcoidosis, Behçet’s disease.
• Post‑infectious or post‑vaccination immune response: Rarely follows viral illness or certain vaccines.
• Paraneoplastic syndromes: Antibodies produced in response to a hidden cancer (e.g., small‑cell lung cancer).
• Ischemic optic neuropathy: Poor blood flow to the optic nerve, often linked to hypertension or diabetes.
• Toxic/nutritional optic neuropathy: Excess methanol, ethambutol, or vitamin B12 deficiency.
• Trauma or compressive lesions: Tumors, aneurysms, or orbital fractures that irritate the nerve.
• Idiopathic: In many cases, no specific cause is identified (often termed “isolated” ON).

Associated Symptoms

While loss of vision is the hallmark, patients frequently report additional signs that help clinicians narrow the cause:

• Pain on eye movement: A classic feature; pain typically worsens with upward or downward gaze.
• Decreased visual acuity: Blurred or dim vision, often unilateral at onset.
• Color vision deficits: Particularly loss of red perception (red desaturation).
• Visual field defects: Central scotoma, altitudinal loss, or diffuse dimming.
• Relative afferent pupillary defect (RAPD): “Marcus Gunn pupil” on swinging‑flashlight test.
• Eye flashing or flickering (photopsia): Less common, may indicate retinal involvement.
• Systemic symptoms: Fever, headache, or signs of infection when an infectious cause is present.
• Neurologic clues: Numbness, weakness, or gait problems suggesting demyelinating disease.

When to See a Doctor

Because optic neuritis can signal serious underlying disease, prompt evaluation is essential. Seek medical care if you notice:

• Sudden vision loss or blurred vision in one eye lasting more than 24 hours.
• Pain worsened by moving the eye.
• Loss of color perception or the appearance of a dark spot in the center of your vision.
• Visual changes in both eyes, especially if accompanied by headache or fever.
• Any neurologic symptoms (e.g., weakness, numbness, difficulty walking).
• A history of recent infection, vaccination, or exposure to toxins.

Even if symptoms improve quickly, an eye‑care professional should confirm the diagnosis and assess for future risk of multiple sclerosis or other conditions.

Diagnosis

Diagnosing optic neuritis involves a blend of clinical examination, imaging, and laboratory testing.

1. Clinical Eye Examination

• Visual acuity testing: Baseline measurement of sharpness of vision.
• Color vision testing: Ishihara plates or Farnsworth D‑15.
• Visual field testing: Automated perimetry to map scotomas.
• Pupillary exam: Detects a relative afferent pupillary defect.

2. Imaging

• Magnetic resonance imaging (MRI) of the brain and orbits with gadolinium: The gold standard. Shows enhancement of the optic nerve and may reveal demyelinating plaques suggestive of MS.
• Optical coherence tomography (OCT): Measures retinal nerve fiber layer thickness; thinning over time correlates with axonal loss.

3. Laboratory Tests

• Blood work to rule out infection (e.g., VDRL for syphilis, Lyme serology), autoimmune disease (ANA, anti‑dsDNA, ACE for sarcoidosis), and nutritional deficiencies (B12, folate).
• Serum anti‑AQP4 and anti‑MOG antibodies when NMOSD or MOG‑associated disease is suspected.
• Lumbar puncture (rare) if CSF analysis is needed to support MS diagnosis.

4. Ancillary Tests

• Visual evoked potentials (VEP): Delayed P100 wave latency confirms demyelination of the optic pathway.

Treatment Options

Therapy aims to reduce inflammation, speed visual recovery, and address the underlying cause.

1. Corticosteroids

• Intravenous methylprednisolone (IVMP): 1 g/day for 3–5 days followed by an oral taper is the most evidence‑based regimen (ONTT study). It speeds visual improvement but does not change final visual outcome.
• Oral prednisone alone: High‑dose oral steroids without IV loading are NOT recommended because they raise relapse risk.

2. Disease‑Modifying Therapies (DMTs)

When ON is associated with MS or NMOSD, long‑term immunomodulation is crucial.

• For MS: interferon‑β, glatiramer acetate, dimethyl fumarate, or newer agents such as ocrelizumab.
• For NMOSD: rituximab, eculizumab, or inebilizumab, which specifically target the immune process.

3. Immunosuppressive Agents

• Mycophenolate mofetil, azathioprine, or cyclophosphamide may be used for refractory autoimmune optic neuritis.

4. Vision Rehabilitation & Supportive Care

• Low‑vision aids: Magnifiers, high‑contrast reading glasses.
• Protective sunglasses: Reduce photophobia.
• Patient education: Emphasize the importance of follow‑up eye exams and neurologic assessments.

5. Home & Lifestyle Measures

• Rest the eyes; avoid prolonged screen time during the acute phase.
• Maintain a balanced diet rich in omega‑3 fatty acids and antioxidants, which may support nerve health.
• Control vascular risk factors (blood pressure, diabetes, cholesterol) to lower ischemic risk.

Prevention Tips

Because many triggers are not fully controllable, prevention focuses on risk‑factor management and early detection:

• Vaccinations: Stay up‑to‑date with recommended vaccines (e.g., influenza, COVID‑19) to avoid infections that can precipitate ON.
• Infection control: Prompt treatment of bacterial or viral infections (e.g., Lyme disease, syphilis) reduces the likelihood of immune‑mediated optic nerve inflammation.
• Autoimmune monitoring: Individuals with diagnosed autoimmune disorders should follow their rheumatologist’s medication plan and routine labs.
• Healthy lifestyle: Regular exercise, smoking cessation, and limiting alcohol protect vascular health.
• Regular eye examinations: Especially for patients with MS, NMOSD, or a prior episode of ON.
• Nutrition: Adequate vitamin B12, folate, and vitamin D levels support myelin health.

Emergency Warning Signs

If you experience any of the following, seek immediate medical attention (go to the emergency department or call emergency services):

• Rapidly worsening vision in one or both eyes.
• Severe, unrelenting eye pain that does not improve with rest.
• Sudden onset of double vision (diplopia) or inability to move the eye.
• Accompanying facial weakness, slurred speech, or loss of coordination—possible brainstem involvement.
• High fever, neck stiffness, or rash suggestive of meningitis or systemic infection.
• Sudden visual loss after head trauma.

---

Sources: Mayo Clinic, National Multiple Sclerosis Society, CDC (Lyme & Syphilis Fact Sheets), NIH – National Eye Institute, Cleveland Clinic, “Optic Neuritis Treatment Trial” (NEJM 2006), WHO – Vision Impairment Fact Sheet.

```